Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
1994-12-12
pubmed:abstractText
The effects of gomisin A, a lignan compound of Schizandra fruits, on hepatocarcinogenesis induced by 3'-methyl-4-dimethylaminoazobenzene (3'-MeDAB) in rats were investigated. Gomisin A inhibited both increases of the number and size of glutathione S-transferase placental form (GST-P)-positive foci, a marker enzyme of preneoplasm, and the population of diploid nuclei, as a proliferative state of hepatocytes, in the liver from rats simultaneously treated with 3'-MeDAB. Gomisin A increased GST activity in the liver, by raising the level of GST 1 and 2 isozymes. 3'-MeDAB increased GST activity and GST-P expression. This high level of GST-P induced by 3'-MeDAB was suppressed by additional treatment with gomisin A. In an experiment on simultaneous treatment, gomisin A increased the biliary excretion of 3'-MeDAB-related aminoazo dyes and decreased the content in the liver of rats fed with 0.06%-3'-MeDAB containing diet. In an experiment on pretreatment with 3'-MeDAB, even though no aminoazo dye was detectable in the liver or bile 2-weeks after cessation of 3'-MeDAB-feeding, gomisin A showed a tendency to reduce the preneoplastic changes of increases in GST-P positive foci and diploid nuclei in the liver. These results suggest that gomisin A inhibits the hepatocarcinogenesis induced by 3'-MeDAB by enhancing the excretion of the carcinogen from the liver and by reversing the normal cytokinesis.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
0918-6158
pubmed:author
pubmed:issnType
Print
pubmed:volume
17
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
808-14
pubmed:dateRevised
2004-11-17
pubmed:meshHeading
pubmed-meshheading:7951143-Animals, pubmed-meshheading:7951143-Cell Division, pubmed-meshheading:7951143-Cell Nucleus, pubmed-meshheading:7951143-Cyclooctanes, pubmed-meshheading:7951143-Diet, pubmed-meshheading:7951143-Dioxoles, pubmed-meshheading:7951143-Drugs, Chinese Herbal, pubmed-meshheading:7951143-Electrophoresis, Polyacrylamide Gel, pubmed-meshheading:7951143-Flow Cytometry, pubmed-meshheading:7951143-Glutathione Transferase, pubmed-meshheading:7951143-Immunoblotting, pubmed-meshheading:7951143-Immunohistochemistry, pubmed-meshheading:7951143-Isoenzymes, pubmed-meshheading:7951143-Lignans, pubmed-meshheading:7951143-Liver, pubmed-meshheading:7951143-Liver Neoplasms, pubmed-meshheading:7951143-Male, pubmed-meshheading:7951143-Methyldimethylaminoazobenzene, pubmed-meshheading:7951143-Ploidies, pubmed-meshheading:7951143-Protein Binding, pubmed-meshheading:7951143-Rats
pubmed:year
1994
pubmed:articleTitle
Inhibition by gomisin A, a lignan compound, of hepatocarcinogenesis by 3'-methyl-4-dimethylaminoazobenzene in rats.
pubmed:affiliation
Research Laboratory for Development of Medicine, Faculty of Pharmaceutical Sciences, Hokuriku University, Kanazawa, Japan.
pubmed:publicationType
Journal Article